QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 27 September 2019Portfolio NewsMisonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys Medical
- 27 September 2019Portfolio NewsDDF notes Ribometrix raises $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform with Investment from DDF
- 24 September 2019Portfolio NewsArtios Pharma Appoints Tania Dimitrova as Chief Business Officer and Expands Presence in the United States
- 9 September 2019SV NewsDDF notes the appointment of Christian Jung, PhD as Partner
- 27 August 2019Portfolio NewsPIONYR Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages
- 13 August 2019Portfolio NewsDeciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
- 12 August 2019Portfolio NewsDDF notes AstronauTx secures £6.5 million Financing with Investment from DDF
- 8 August 2019Portfolio NewsLilly, Evidation Health and Apple Study Shows Personal Digital Devices May Help in the Identification of Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia
- 7 August 2019Portfolio NewsQ&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy.
- 22 July 2019Portfolio NewsWashington Regional and Urgent Team Family of Urgent Care Join Forces
- 17 July 2019Portfolio NewsKarus Therapeutics Strengthens Clinical Leadership Team with Appointment of Dr Hilary McElwaine-Johnn, MD as Chief Medical Officer
- 8 July 2019Portfolio NewsDDF notes MedaRed Raises $6.5 Million Financing with Investment from DDF